Anzeige
Mehr »
Login
Dienstag, 01.04.2025 Börsentäglich über 12.000 News von 695 internationalen Medien
Kurs-Explosion voraus?: Diese kaum bekannte Aktie bohrt jetzt im Hotspot - und du erfährst es als Erster!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A40WGA | ISIN: GB00BQVXM815 | Ticker-Symbol: 5HU0
Frankfurt
01.04.25
09:12 Uhr
2,220 Euro
0,000
0,00 %
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
HEMOGENYX PHARMACEUTICALS PLC Chart 1 Jahr
5-Tage-Chart
HEMOGENYX PHARMACEUTICALS PLC 5-Tage-Chart
RealtimeGeldBriefZeit
2,2202,44011:03

Aktuelle News zur HEMOGENYX PHARMACEUTICALS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MoHemogenyx Pharmaceuticals PLC Announces Total Voting Rights85LONDON, GB / ACCESS Newswire / March 31, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the total...
► Artikel lesen
MoHemogenyx Pharma Plc - Total Voting Rights1
24.03.Hemogenyx Pharmaceuticals PLC Announces First Patient Safety148THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIIONS...
► Artikel lesen
24.03.Hemogenyx Pharma Plc - First Patient Safety1
17.03.Hemogenyx Pharmaceuticals PLC Announces Recruitment of Second Patient for Clinical Trials173Recruitment of Second Patient for HG-CT-1 Clinical Trial LONDON, GB / ACCESS Newswire / March 17, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce the recruitment of the second...
► Artikel lesen
17.03.Hemogenyx Pharma Plc - Recruitment of Second Patient for Clinical Trials-
13.03.Hemogenyx Pharma Plc - Conversion of convertible loan notes1
11.03.Hemogenyx Pharmaceuticals PLC Announces Institutional Investment104Institutional backing of £709,200 for continuing Phase 1 Clinical Trials LONDON, UNITED KINGDOM / ACCESS Newswire / March 11, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) ("Hemogenyx Pharmaceuticals"...
► Artikel lesen
HEMOGENYX PHARMACEUTICALS Aktie jetzt für 0€ handeln
11.03.Hemogenyx Pharma Plc - Institutional investment1
24.02.Hemogenyx Pharmaceuticals PLC Announces First-in-Human Treatment with HG-CT-1154THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU WHICH IS PART OF DOMESTIC UK LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS...
► Artikel lesen
24.02.Hemogenyx Pharma Plc - First-in-Human Treatment with HG-CT-1-
19.02.Hemogenyx Pharmaceuticals PLC Announces Issue of Convertible Loan Notes312LONDON, UK / ACCESS Newswire / February 19, 2025 / NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES, AUSTRALIA, CANADA...
► Artikel lesen
19.02.Hemogenyx Pharmaceuticals sammelt 285.000£ durch Wandelanleihen ein3
19.02.Hemogenyx Pharmaceuticals raises £285,000 via convertible notes3
19.02.Hemogenyx Pharma Plc - Issue of convertible loan notes1
31.01.Hemogenyx Pharma Plc - Total Voting Rights1
08.01.Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000201LONDON, UK / ACCESSWIRE / January 8, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased to announce that it has raised £340,000 through the issue of 100,000 new ordinary shares ("Placing Shares")...
► Artikel lesen
08.01.Hemogenyx Pharma Plc - Placing to raise £340,0001
02.01.Hemogenyx Pharma Plc - Change of Company Secretary and Registered Office-
31.12.24Hemogenyx Pharma Plc - Total Voting Rights-
Seite:  Weiter >>
51 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1